BioAge Labs, Inc.

BIOA

BioAge Labs, Inc.

BIOA

Insider Sentiment (TTM):

Last Purchase:2024-10-03Last Sale:2026-04-01Shares Purchased (TTM):0Shares Sold (TTM):378,123

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:33,637,631Shares Outstanding:42,480,488Institutional Ownership Pct.:79.18%

Earnings Market Reaction:

Filing Date:2026-05-08Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

BioAge Labs, Inc. (BIOA) — SEC Financial Statements & Analysis

BioAge Labs, Inc. (BIOA) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Assets Current
Cash And Cash Equivalents At Carrying Value	242	189	216	220	257	354	334
Marketable Securities Current	141	92	70	77	63	0	-
Accounts Receivable Net Current	1	1	1	1	0	0	-
Prepaid Expense And Other Assets Current	8	5	5	4	4	3	2
Assets Current	392	287	291	302	325	357	336
Long Term Investments	0	0	0	0	0	0	0
Marketable Securities	2	4	10	16	15	0	-
Property Plant And Equipment Net	1	1	1	1	1	1	1
Operating Lease Right Of Use Asset	3	3	3	3	3	0	0
Other Assets Noncurrent	0	0	0	0	0	0	-
Assets	398	295	305	322	344	358	337
Liabilities
Liabilities Current
Accounts Payable Current	3	3	5	1	4	2	2
Long Term Debt Current	1	3	4	6	6	6	6
Operating Lease Liability Current	1	1	1	1	1	0	0
Contract With Customer Liability Current	6	6	8	8	8	8	-
Liabilities Current	16	20	24	23	24	28	19
Contract With Customer Liability Noncurrent	-	0	1	2	3	5	-
Long Term Debt Noncurrent	-	0	0	0	1	3	4
Derivative Liabilities Noncurrent	0	0	0	0	0	0	-
Operating Lease Liability Noncurrent	2	2	2	3	3	0	-
Liabilities	19	23	28	27	31	35	24
Temporary Equity Carrying Amount Attributable To P…	-	0	-	-	-	0	0
Stockholders Equity
Preferred Stock Value	0	0	0	0	-	0	-
Common Stock Value	0	0	0	0	-	0	-
Additional Paid In Capital	735	605	585	582	579	576	545
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	0	0	0	0
Retained Earnings Accumulated Deficit	-356	-333	-307	-287	-266	-253	-232
Stockholders Equity	379	272	277	295	313	323	314
Liabilities And Stockholders Equity	398	295	305	322	344	358	337
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0
Temporary Equity Par Or Stated Value Per Share	-	-	-	-	-	0	0
Common Stock Shares Authorized	500	500	500	500	500	500	500
Common Stock Shares Issued	44	37	36	36	36	36	34
Temporary Equity Shares Issued	-	-	-	-	-	0	0
Shares Outstanding	44	37	36	36	36	36	34
Temporary Equity Shares Outstanding	-	-	-	-	-	0	0
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-3.89%	32.07%	-	-	-	-	-	-	-	-	-	-
2025	0.25%	6.33%	16.96%	13.86%	25.17%	75.52%	27.04%	85.81%	151.81%	14.77%	9.62%	11.98%
2024	-	-	-	-	-	-	-8.83%	-73.33%	-73.81%	-15.98%	-7.76%	1.60%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Liquidity Ratios
Current Ratio	24.76	14.24	11.87	13.21	13.68	12.86	17.63
Quick Ratio	24.26	14.00	11.69	13.04	13.52	12.76	17.53
Working Capital	376.03M	266.66M	266.34M	278.86M	301.08M	329.33M	317.39M
Leverage & Debt
Debt to Equity	0.05	0.08	0.10	0.09	0.10	0.11	0.08
Debt Ratio	0.05	0.08	0.09	0.08	0.09	0.10	0.07
Efficiency & Turnover
Asset Turnover TTM	0.03	0.03	0.02	0.01	-	-	-
Days Sales Outstanding TTM	18.93	31.20	31.77	56.98	-	-	-
Receivables Turnover TTM	19.28	11.70	11.49	6.41	-	-	-
Per Share Metrics
Diluted EPS TTM	-2.12	-2.24	-2.86	-2.95	-	-	-
Free Cash Flow Per Share TTM	-2.09	-2.29	-1.65	-2.51	-	-	-
Dividend Per Share TTM	0.00	0.00	0.00	0.00	-	-	-
Margin Metrics
Operating Profit Margin TTM	-985.93%	-1,031.46%	-1,990.89%	-3,091.15%	-	-	-
Net Profit Margin TTM	-871.75%	-896.11%	-1,730.00%	-2,733.63%	-	-	-
Valuation Metrics
P/E TTM	-8.26	-5.90	-2.06	-1.40	-	-	-
P/B	1.96	1.75	0.76	0.50	0.43	0.58	2.09
P/S TTM	72.02	52.85	35.63	38.33	-	-	-
Market Cap	742.98M	475.39M	210.80M	148.06M	134.80M	186.32M	654.19M
Enterprise Value	502.37M	289.15M	-648.78K	-66.67M	-115.63M	-159.53M	329.65M
Calculated Values
Free Cash Flow TTM	-88.63M	-82.35M	-59.15M	-89.81M	-	-	-
Net Debt	-240.62M	-186.24M	-211.45M	-214.73M	-250.43M	-345.85M	-324.53M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-04-01Sale

Owner: Rubin, Paul D

Title: Chief Medical Officer

Shares: 8,820

Price/Share: $17.81

Value: $157,084.20

Shares Owned: -

Relationship: Officer

Ownership: Direct

2026-03-02Sale

Owner: Rubin, Paul D

Title: Chief Medical Officer

Shares: 7,433

Price/Share: $20.30

Value: $150,889.90

Shares Owned: -

Relationship: Officer

Ownership: Direct

2026-02-02Sale

Owner: Rubin, Paul D

Title: Chief Medical Officer

Shares: 7,433

Price/Share: $18.75

Value: $139,368.75

Shares Owned: -

Relationship: Officer

Ownership: Direct

2026-01-13Sale

Owner: Fortney, Kristen

Title: Chief Executive Officer

Shares: 233,107

Price/Share: $18.12

Value: $4,223,898.84

Shares Owned: 976,949

Relationship: Director,Officer

Ownership: Direct

2026-01-13Sale

Owner: Goldstein, Dov A Md

Title: Chief Financial Officer

Shares: 27,000

Price/Share: $19.88

Value: $536,760.00

Shares Owned: 22,408

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-04-01	Rubin, Paul D	Officer	Chief Medical Officer	Direct	Sale	8,820	17.81	$157,084.20	0	4
2026-03-02	Rubin, Paul D	Officer	Chief Medical Officer	Direct	Sale	7,433	20.30	$150,889.90	0	4
2026-02-02	Rubin, Paul D	Officer	Chief Medical Officer	Direct	Sale	7,433	18.75	$139,368.75	0	4
2026-01-13	Fortney, Kristen	Director,Officer	Chief Executive Officer	Direct	Sale	233,107	18.12	$4,223,898.84	976,949	4
2026-01-13	Goldstein, Dov A Md	Officer	Chief Financial Officer	Direct	Sale	27,000	19.88	$536,760.00	22,408	4
2026-01-02	Rubin, Paul D	Officer	Chief Medical Officer	Direct	Sale	7,433	12.85	$95,514.05	0	4
2025-12-09	Rubin, Paul D	Officer	Chief Medical Officer	Direct	Sale	18,000	12.00	$216,000.00	0	4
2025-12-04	Rubin, Paul D	Officer	Chief Medical Officer	Direct	Sale	68,897	10.19	$702,060.43	0	4
2024-10-03	Pande, Vijay Satyanand	Director	-	Indirect	Purchase	25,306	19.90	$503,589.40	1,119,195	4
2024-09-27	Healy, James	Director	-	Indirect	Purchase	666,665	18.00	$11,999,970.00	2,227,124	4
2024-09-27	Barton, Shane	Officer	Principal Accounting Officer	Direct	Purchase	2,632	18.00	$47,376.00	2,632	4
2024-09-27	Enright, Patrick G	Director	-	Indirect	Purchase	400,000	18.00	$7,200,000.00	1,710,589	4
2024-09-27	Chen, Bihua, Cormorant Pr…	Other	-	Indirect	Purchase	450,000	18.00	$8,100,000.00	1,629,529	4
2024-09-27	Pande, Vijay Satyanand	Director	-	Indirect	Purchase	900,000	18.00	$16,200,000.00	900,000	4
2024-09-27	Hemrajani, Rekha	Director	-	Direct	Purchase	3,000	18.00	$54,000.00	3,000	4/A
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

79.18%

Inst. Shares: 33,637,631

Shares Outstanding: 42,480,488

2025-12-31

64.10%

Inst. Shares: 23,033,559

Shares Outstanding: 35,932,914

2025-09-30

59.11%

Inst. Shares: 21,190,018

Shares Outstanding: 35,850,037

2025-06-30

57.53%

Inst. Shares: 20,624,485

Shares Outstanding: 35,850,037

2025-03-31

56.30%

Inst. Shares: 20,183,518

Shares Outstanding: 35,850,037

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	33,637,631	42,480,488	79.18%
2025-12-31	23,033,559	35,932,914	64.10%
2025-09-30	21,190,018	35,850,037	59.11%
2025-06-30	20,624,485	35,850,037	57.53%
2025-03-31	20,183,518	35,850,037	56.30%
2024-12-31	19,578,137	32,179,563	60.84%
2024-09-30	20,178,630	31,451,220	64.16%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

BioAge Labs, Inc. (BIOA) — SEC Financial Statements & Analysis

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.